Nelson H S, Oppenheimer J, Buchmeier A, Kordash T R, Freshwater L L
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA.
J Allergy Clin Immunol. 1996 Jun;97(6):1193-201. doi: 10.1016/s0091-6749(96)70184-7.
Immediate skin testing is generally the preferred method for establishing the presence of allergy in clinical practice. There is no agreement, however, as to whether intradermal testing should be routinely performed if skin prick test results are negative.
The study was done to address the value of intradermal skin testing in the diagnosis of clinically significant sensitivity to grass pollen in patients exhibiting negative skin prick test responses to timothy extract.
Four groups were studied. Group I had a history of seasonal allergic rhinitis, negative skin prick test responses to timothy and Bermuda grass, but positive intradermal skin test responses to timothy grass. Group II had a history of seasonal allergic rhinitis and positive skin prick test responses to timothy grass. Group III had a history of seasonal allergic rhinitis but had negative responses to both prick and intradermal testing with timothy and Bermuda grass. Group IV had no history of rhinitis, had negative responses to skin testing with a panel of locally important allergens, as well as Bermuda and timothy grass, and had a serum IgE value of less than 20 IU/ml. Clinical sensitivity to grass was assessed by two methods: (1) nasal challenge with threefold increasing amounts of timothy pollen performed out of the pollen season and (2) correlation of subjects' daily symptom and medication scores with daily grass pollen counts during the grass pollen season.
On the basis of nasal challenge with timothy grass, pollen allergic reactions were present in 11% of group I, 68% of group II, 11% of group III, and 0% of group IV. As determined by correlation of symptoms during the grass pollen season with grass pollen counts, 22% of group I, 64% of group II, 21% of group III, and 0% of group IV were considered allergic. If both criteria were required for a diagnosis of clinical allergy to grass, the percent positive was 0 for group I, 46 for group II, 0 for group III, and 0 for group IV.
Under the conditions of this study the presence of a positive intradermal skin test response to timothy grass (1000 AU/ml) in the presence of a negative skin prick test response to timothy grass (100,000 AU/ml) did not indicate the presence of clinically significant sensitivity to timothy grass, and by inference, to other cross-reacting grasses.
在临床实践中,即时皮肤试验通常是确定过敏是否存在的首选方法。然而,对于皮肤点刺试验结果为阴性时是否应常规进行皮内试验,尚无定论。
本研究旨在探讨皮内皮肤试验在诊断对梯牧草提取物皮肤点刺试验反应阴性的患者中对草花粉临床显著敏感性的价值。
研究分为四组。第一组有季节性变应性鼻炎病史,对梯牧草和百慕大草的皮肤点刺试验反应阴性,但对梯牧草的皮内皮肤试验反应阳性。第二组有季节性变应性鼻炎病史,对梯牧草的皮肤点刺试验反应阳性。第三组有季节性变应性鼻炎病史,但对梯牧草和百慕大草的点刺试验及皮内试验均为阴性。第四组无鼻炎病史,对一组当地重要变应原以及百慕大草和梯牧草的皮肤试验均为阴性,血清IgE值小于20 IU/ml。通过两种方法评估对草的临床敏感性:(1)在花粉季节之外用梯牧草花粉量呈三倍增加进行鼻腔激发试验;(2)在草花粉季节将受试者的每日症状和用药评分与每日草花粉计数进行相关性分析。
基于梯牧草鼻腔激发试验,第一组11%、第二组68%、第三组11%、第四组0%出现花粉过敏反应。根据草花粉季节症状与草花粉计数的相关性分析,第一组22%、第二组64%、第三组21%、第四组0%被认为过敏。如果诊断对草的临床过敏需要满足两个标准,则第一组阳性率为0,第二组为46,第三组为0,第四组为0。
在本研究条件下,对梯牧草(100,000 AU/ml)皮肤点刺试验反应阴性而对梯牧草(1000 AU/ml)皮内皮肤试验反应阳性,并不表明存在对梯牧草临床显著的敏感性,由此推断,对其他交叉反应的草也不存在临床显著敏感性。